NIAID Archive
-
February 14, 2019
Probing H. pylori cancer protein
Understanding how a bacterial protein that influences the risk of stomach cancer is produced could guide new strategies for treatment. -
January 31, 2019
Destructive ‘telegrams’ in asthma
Vanderbilt investigators have discovered that certain microRNAs — "telegram"-like signals — increase after the induction of allergic airway inflammation. -
January 17, 2019
Pain relievers a risk for C. diff?
A link between anti-inflammatory drugs such as ibuprofen and C. diff infection suggests caution against overusing such drugs in patients at high risk for infection. -
November 29, 2018
Parsing diabetic skin infections
Vanderbilt researchers have discovered a role for an inflammatory mediator in diabetic skin infections, suggesting new therapeutic targets for this common complication of diabetes. -
October 26, 2018
Fetal membranes and microbial threats
Understanding how cells communicate in the membranes surrounding the developing fetus could suggest new strategies for preventing infections, premature birth and adverse pregnancy outcomes. -
October 12, 2018
Asthma’s androgen connection
New findings may explain why the prevalence of asthma is higher in women and suggest that testosterone derivatives may be useful for treating more severe types of asthma. -
September 13, 2018
Healthy antibodies reverse diabetes
Vanderbilt researchers have discovered that IgM-type antibodies appear to play a protective role to prevent the development of type 1 diabetes — and that purified IgM antibodies can reverse the disease.